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)e existence of a sarcoidosis-lymphoma syndrome has been previously proposed since the relation between sarcoidosis and an
increased risk of lymphoproliferative disorders is well established. Multiple myeloma is a malignant multifocal proliferation of
clonal plasma cells within the bone marrow, and its association with sarcoidosis has been rarely described. We present a
concurrent diagnosis of sarcoidosis and multiple myeloma and make a brief analysis of the reported cases in the literature. A 65-
year-old woman underwent surgery for the excision of a wrist mass that presented 3 years before. Histological analysis showed
sarcoid-type epithelioid granulomas without necrosis, establishing soft tissue sarcoidosis. Further evaluation revealed marked
interstitial lung parenchyma lesions and large intrathoracic adenopathies. Bronchofibroscopy with transbronchial biopsy
confirmed lung sarcoidosis. In addition, blood analysis showed monoclonal IgG kappa gammopathy. A bone marrow biopsy
confirmed hypercellularity with 60% plasma cells and plasmocyte infiltration. )us, the diagnosis of systemic sarcoidosis and
multiple myeloma was established simultaneously. In a brief review of the literature, we identified 33 reports of cases with both
sarcoidosis and multiple myeloma.We point out the importance of a high level of suspicion for the association of sarcoidosis with
malignant haematological diseases such as multiple myeloma.
1. Introduction
Sarcoidosis is a T-cell-mediated immunological response
against an unknown environmental trigger in a susceptible
host. Noncaseating granulomas, consisting of compact and
centrally organized collections of CD4+ T cells, macro-
phages, and epithelioid cells, are the hallmark of sarcoidosis
and the outcome of an unbalanced T-helper 1 immune
response [1, 2]. Multiple myeloma (MM) is a malignant
multifocal proliferation of clonal plasma cells within the
bone marrow, associated with skeletal destruction, serum
monoclonal gammopathy, and end-organ sequelae [3].
Brincker [4] described the sarcoidosis-lymphoma syndrome
in 1986 for the particular association between sarcoidosis
and lymphoproliferative disorders (LD); however, the as-
sociation between sarcoidosis and MM has been rarely re-
ported and the explanation for this relation remains unclear
and controversial. We describe a case of sarcoidosis asso-
ciated with MM and present a brief analysis of published
cases in the literature.
2. Case Report
A 65-year-old Caucasian women, retired cook, was referred
to our outpatient clinic due to a three-year history of a
painless mass on the dorsal side of the right wrist. Her
medical background was positive for type 2 diabetes mel-
litus, dyslipidaemia, bronchitis, and venous thrombosis of
the right eye. )e wrist lesion had been growing gradually
and affected finger movement. )ere was no history of blunt
or penetrating trauma.
An ultrasound, complemented with nuclear magnetic
resonance, identified a lesion on the dorsal plane of the right
wrist, extending to the inner face, but without vascular or
tendinous invasion, measuring about 100× 60×18mm in
diameter and having well-defined limits (Figure 1). After
surgery for lesion removal, histological analysis showed an
extensive granulomatous process without necrosis, con-
sisting of sarcoid-type epithelioid granulomas. )e patient
also complained of long-term intermittent nodular skin
lesions on both legs, dry cough, and dyspnoea, for which she
had been previously prescribed bronchodilators with little
symptomatic relief. Physical examination revealed painless
bilateral supraclavicular lymphadenopathies, bibasilar
coarse crackles, and nodular skin lesions scattered along
both inferior limbs (erythema nodosum). )ere were no
other palpable lymph nodes, hepatosplenomegaly, fever,
night sweats, or constitutional symptoms.
Laboratory studies showed haemoglobin 9.7 g/dL (ref-
erence range 11.5–16.5 g/dL), white blood cells count of
4.6×109/L (reference range 4–11× 109/L), C-reactive pro-
tein of 0.87mg/dL (reference range <0.30mg/dL), eryth-
rocyte sedimentation rate of 83mm (reference range
<20mm), serum angiotensin converting enzyme (ACE) of
141.28U/L (reference range 12–68U/L), albumin of 3.66 g/
dL (reference range 3.97–4.94 g/dL), and total serum protein
level of 8.40 g/dL (reference range 6.40–8.20 g/dL). Serum
protein electrophoresis revealed a monoclonal band, con-
firmed by immunofixation to be immunoglobulin IgG
kappa. Further quantification of serum immunoglobulins
showed an elevated IgG level of 3120mg/dL (reference range
70–1600mg/dL), with normal IgM and IgA, and beta-2
microglobulin of 2.09mg/dL (reference range 0.67–
1.31mg/dL). Mantoux assay and Bence Jones proteinuria
quantification were negative, and both renal function and
serum calcium were within the normal range. )e screening
for HIV and hepatitis B and C was negative.
A high-resolution computed tomography of the chest
showed large mediastinal and axillary adenopathies with
extensive conglomerates, associated with marked and diffuse
permeability of the entire pulmonary parenchyma, thick-
ening of the interlobular septa, and fine bronchovascular and
subpleural micronodularity (Figure 2).
)e patient’s lung function testing revealed a mild re-
strictive pattern with decreased diffusion capacity. A
bronchofibroscopy with transbronchial biopsy and bron-
chioalveolar lavage was performed. Respiratory tract fluid
analysis showed an increased CD4/CD8 ratio of 9.02, and both
acid-fast staining (Ziehl–Neelsen coloration) and mycobacte-
rial culture were negative. Bronchial biopsy histological results
revealed mild chronic inflammatory infiltrate with multiple
nonnecrotizing sarcoid-type epithelioid granulomas and giant
multinucleated Langerhans cells (Figures 3(a) and 3(b)). )e
patient also underwent a scintigraphy with gallium 67, which
documented pathological uptake in the lungs, axillary and
inguinal regions, and several cutaneous foci on the lower limbs.
Ophthalmologic evaluation was consistent with ocular sar-
coidosis. For further evaluation of serum monoclonal IgG
kappa gammopathy, a bone marrow aspirate and biopsy were
performed, showing a hypercellular bone marrow with 60%
plasma cells and plasmocyte infiltration with K light chain
restriction, respectively (Figures 3(c) and 3(d)).
(a)
(b) (c)
Figure 1: Magnetic resonance images in T1-weighted axial view (a), T2-weighted axial view (b), and T2-weighted sagital view (c),
identifying a lesion on the dorsal plane of the right wrist, extending to the inner face but without vascular or tendinous invasion, measuring
about 100× 60×18mm in diameter, with well-defined limits.
Figure 2: Chest high-resolution computed tomography image
showing marked and diffuse alteration of pulmonary parenchyma
permeability, thickening of the interlobular septa, and fine bron-
chovascular and subpleural micronodularity, associated with me-
diastinal lymphadenopathy.
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Hence, a simultaneous diagnostic of systemic sarcoidosis
and multiple myeloma stage I according to the International
Staging System was established. )e patient was started on
prednisolone 60mg/day with clinical and biochemical im-
provement. Bone marrow plasma cell infiltration dropped
to 28%, and IgG immunoglobulin and ACE returned to
normal values. Although a slow reduction of steroid therapy
(to 5mg/day) was achieved in time, previous oral antidia-
betic therapy became insufficient and prompted insulin
introduction.
3. Discussion
Only few cases of sarcoidosis in association with MM have
been reported in the literature, so there is not enough sci-
entific evidence available to support a causal relation for the
occurrence of these two diseases. Nonetheless, epidemio-
logical data highlight the higher risk for lymphoproliferative
disease development in sarcoidosis patients [5–8].
Brincker and Wilbek [5] published the first study re-
garding the association between sarcoidosis and malignant
diseases in 1974. In a retrospective analysis of 2544 Danish
sarcoidosis patients, the risk of lymphoproliferative diseases
was found to be 11.5 times higher than expected, the most
common being Hodgkin’s disease. )at same year, Selroos
et al. [9] reported the first known case of sarcoidosis as-
sociated with MM, in a 56-year-old Finnish woman. Based
on previous publications, Brincker [4] hypothesised the
existence of a sarcoidosis-lymphoma syndrome, anchored
on the following features: lymphoproliferative disorders
always followed sarcoidosis, the median age of sarcoidosis
diagnosis in patients with lymphoma was 10 years later than
those with sarcoidosis diagnosed first, and B-cell Hodgkin’s
malignancy was more frequent then T-cell lymphomas.
In our review of the literature, 33 cases with both sar-
coidosis and MM were identified although patient charac-
teristics and diagnostic information were not available for all
of them [4, 6–25]. Data analyses showed female gender
predominance, with a median age at sarcoidosis diagnosis of
46 years (24–65). Despite being about 10 years lower than
previous authors have reported, it is still higher than the
median age for sarcoidosis diagnosis in the general pop-
ulation [3, 16, 19]. )e median time interval between sar-
coidosis and MM diagnosis was 8.2 years (0–27), but in 9
cases a simultaneous diagnosis of both diseases was reported.
)ese data are in favour of Brincker’s [4] hypothesis that
malignant haematological diseases are associated with
chronic active sarcoidosis in middle-aged patients. Also in
accordance with this predisposing relation is the fact that in
almost all patients, sarcoidosis preceded the diagnosis of
Figure 3: Histological analysis: transbronchial biopsy (a, b) revealing granulomatous inflammatory process compatible with lung sar-
coidosis; bone marrow biopsy showing hypercellularity with plasmocyte infiltration (c) and kappa light chain restriction (d).
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MM. With respect to MM, IgG was the most common
monoclonal protein reported, followed by IgA and IgM.
)e explanation for the relationship between sarcoidosis
and lymphoproliferative disorders, particularly MM, is still
controversial and unknown. One possible link between
sarcoidosis and MM is the polyclonal hyper-
gammaglobulinemia induced by sarcoidosis chronic in-
flammatory response. )is continuous state of stimulation
results in prolonged B cell and plasma cell half-life, which in
addition to immune system imbalance in sarcoidosis pa-
tients, predisposes for genetic mutations and might lead to
haematological malignancy development [16, 20]. Recent
studies have highlighted the potential role of TH17 cells and
Treg cells in sarcoidosis and MM immune mechanisms [1].
Despite MM being a primary B-cell malignancy, both
quantitative and functional T-cell abnormalities have been
demonstrated to occur in this disease.
In our case, sarcoidosis diagnosis was first made after a
soft tissue lesion excision in a 65-year-old woman. Although
both sarcoidosis and MM were diagnosed simultaneously,
previous respiratory symptoms suggest that sarcoidosis
pulmonary involvement was already present years before
andmisdiagnosed as bronchitis.)is fact might also account
for the older age at the time of the diagnosis of sarcoidosis.
No usual abnormalities related to MM, such as lytic lesions
or renal function impairment, were present at the time of
diagnosis, and only the serum protein electrophoresis
monoclonal band called the attention to a possible un-
derlying disease other than sarcoidosis. We aim to call the
attention to the possibility of LD development in patients
with sarcoidosis. A high level of suspicion should always be
present both at the time of diagnosis as well as during follow-
up since LD seems to develop years after the diagnosis of
sarcoidosis.
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